Sort
64,565 grants matching “drug discovery”
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN)
$1,486,194Leah Helane Rubin · Johns Hopkins University · P30 · FY2023 · MH
Center for Systems Analysis of the Cancer Regulome
$1,486,138Ilya Shmulevich · Institute For Systems Biology · U24 · FY2011 · CA
Discovery to Implementation & Back: Research Translation for the HIV/SU Epidemic
$1,486,070Sherry Deren · New York University · P30 · FY2015 · DA
Comparative Biology of Tissue Repair, Regeneration and Aging
$1,485,267Iain A. Drummond · Mount Desert Island Biological Lab · P20 · FY2021 · GM
Pharmacogenomics of Anti-platelet Agents for CVD Prevent
$1,485,240Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2006 · GM
Prostate Cancer: Transition to Androgen - Independence (CA77739)
$1,485,030Frank S French · Univ Of North Carolina Chapel Hill · P01 · FY2012 · CA
SPORE IN PROSTATE CANCER
$1,484,662Johns Hopkins University · P50 · FY2002 · CA
Discovery of Anticancer Agents of Diverse Natural Origin
$1,484,104Alan Douglas Kinghorn · Ohio State University · P01 · FY2014 · CA
Dietary Biomarkers Development Center at Harvard University
$1,484,048Frank B Hu · Harvard School Of Public Health · U2C · FY2022 · DK
Genome Sequencing of Toxoplasma gondii
$1,483,840Institute For Genomic Research · U01 · FY2001 · AI
Translational and clinical studies targeting y-globin modulation
$1,483,445Vijay Ganesh Sankaran · Boston Children'S Hospital · U01 · FY2017 · HL
Translational and clinical studies targeting y-globin modulation
$1,483,445Vijay Ganesh Sankaran · Boston Children'S Hospital · U01 · FY2016 · HL
CANCER RESEARCH INFRASTRUCTURE DEVELOPMENT
$1,482,951Shafiq A Khan · Clark Atlanta University · G12 · FY2015 · MD
Medical Scientist Training Program
$1,482,940Christopher S. Williams · Vanderbilt University · T32 · FY2022 · GM
Development of novel NLRP3 inflammasome inhibitors for intervening in Alzheimer's disease
$1,482,927Shijun Zhang · Virginia Commonwealth University · U01 · FY2025 · AG
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
$1,482,247Susan Sheps Margulies · University Of Pennsylvania · U01 · FY2011 · NS
Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
$1,482,023Tor C. Savidge · Baylor College Of Medicine · U01 · FY2019 · AI
Development and Commercialization of the Microphysiological Systems Database as a Sustainable Resource
$1,481,809Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U24 · FY2022 · TR
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$1,481,400Matthew D Disney · Scripps Florida · P01 · FY2017 · NS
Translational Immunology research: a support for clinical immunological research
$1,481,347Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2019 · AR
Target Identification via Haplo Insufficiency Profiling
$1,481,188Stanford University · R33 · FY2001 · CA
TOPIC 356: FLUOROGENIC ASSAY PLATFORM FOR CIRCULAR RNA DETECTION
$1,480,983Balajee Somalinga · Lucerna, Inc. · N44 · FY2019 · CA
Development of a PIKFYVE antisense oligonucleotide treatment for FTD
$1,480,550Samuel V Alworth · Acurastem, Inc. · R44 · FY2022 · NS
Base-Editing the Cancer Kinome to Enable Drug Discovery
$1,480,500Neil Vasan · Columbia University Health Sciences · DP2 · FY2023 · CA
Epigenetic drivers of quiescence in artemisinin-resistant Plasmodium falciparum malaria
$1,480,500Jennifer L. Small-Saunders · Columbia University Health Sciences · DP2 · FY2024 · AI